Sol-Gel Stock (NASDAQ:SLGL)


ForecastRevenueOwnershipFinancialsChart

Previous Close

$1.65

52W Range

$0.33 - $1.65

50D Avg

$0.57

200D Avg

$0.71

Market Cap

$25.77M

Avg Vol (3M)

$345.11K

Beta

1.60

Div Yield

-

SLGL Company Profile


Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

36

IPO Date

Feb 01, 2018

Website

SLGL Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 22
Collabrations-
License$3.52M

Fiscal year ends in Dec 23 | Currency in USD

SLGL Financial Summary


Dec 23Dec 22Dec 21
Revenue$1.55M$3.88M$31.27M
Operating Income$-29.36M$-16.24M$2.08M
Net Income$-27.24M$-13.60M$4.36M
EBITDA$-29.02M$-15.68M$2.96M
Basic EPS$-1.01$-0.59$0.18
Diluted EPS$-1.01$-0.59$0.18

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
AVTEAerovate Therapeutics, Inc.
JANXJanux Therapeutics, Inc.
PMVPPMV Pharmaceuticals, Inc.
ANTXAN2 Therapeutics, Inc.
MLYSMineralys Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
MNOVMediciNova, Inc.
RZLTRezolute, Inc.
PEPGPepGen Inc.
ANEBAnebulo Pharmaceuticals, Inc.
PHVSPharvaris N.V.
ADAGAdagene Inc.